I love that Gates is driving money into this needed area. We need new ways of attacking cures and the tech arena should be the driver not science. IMO, traditional science has gotten in the way and their agenda isn't where it needs to be: to find a a cure and save lives (take cancer research for instance).
Why I’m Digging Deep Into Alzheimer’s
141–150 of 192 posts
Re: Why I’m Digging Deep Into Alzheimer’s
#142Funny, I remember contacting the Gates foundation many years ago now about chronic illnesses and the then-new discovery of ipRGCs/pRGCs (which we will find have a critical role in Alzheimer's) and hitting a total brick wall. Paraphrasing them, "this wouldn't help the third world" - we know better now.
As a rule when children normally live to adulthood population growth halts soon after.
Re: Why I’m Digging Deep Into Alzheimer’s
#143Earlier quoted context omitted.
Thanks. I’m still not understanding how so many people could acquire Lyme disease and not have any of the other symptoms.
Because Lyme is often asymptomatic, other than the initial rash!
Re: Why I’m Digging Deep Into Alzheimer’s
#144The documentary "Under our Skin" details Alan MacDonald's breakthrough research on how Lyme disease causes Alzheimers. The 4 minute trailer is worth a watch[1], but basically Lyme disease is found in 7 or 10 brains of Alzheimers patients (small sample set). The Lyme disease spirochete literally drills countless pathways in the brain and that causes slow dementia. That spirochete also creates a biofilm which makes it…
As for how a citizen scientist proceeds, go to pubmed.com and read the abstracts of at least 400,000 medical articles. I did.
I doubt there are 400,000 papers worth reading in all of medicine. A major skill in research is understanding what to read, and how carefully.
Prepping to write a review usually involves about 150 articles, for me. About 50 of them just need a cursory look, and the abstract often suffices. Another 80 or so need some more attention; you might be looking for patterns in the methods used, cross-referencing results, figuring out what labs are doing what, tracking authors over time, etc. This is how you understand the state of a field.
The last 20 or so are the bulk of your time. A few are genuinely excellent and will be a highlight of the review. Some are simply solid work that requires a good amount of attention. A fair number are terrible and highly misleading. These are the papers that look okay, but have some flaws that need to be addressed by the field at large. It takes some tact to write about these, but it's usually not too bad.
Finding good authors, especially ones that write good reviews, can get you up to speed in a field in an afternoon. An evening chasing down citations and digging a bit on your own, and you're probably about where Bill was with this. Since Alzheimer's is a pretty big subject requiring familiarity with a variety of topics, I'd give it two weeks.
Re: Why I’m Digging Deep Into Alzheimer’s
#145I love that Gates is driving money into this needed area. We need new ways of attacking cures and the tech arena should be the driver not science. IMO, traditional science has gotten in the way and their agenda isn't where it needs to be: to find a a cure and save lives (take cancer research for instance).
I don't understand why you think tech companies will be any better at this than biomedical companies. All businesses have the same incentives to make things chronic issues (subscription revenue!) rather than curing them.
Re: Why I’m Digging Deep Into Alzheimer’s
#146It's great to see more investment into this disease. When my grandma fought Alzheimer's over the span of a decade it was very striking to see that the effect of a lack of hydration and the disease itself kind of overlapped. When she had a particularly bad day we used to give her a saline IV and you could immediately notice how she cleared up and regained her brain powers after each IV. I'm not up to date on current r…
There have been attempts to build a wearable hydration sensor but no one has made the technology work reliably yet. It's a big potential market if someone can find a solution.
https://www.dcrainmaker.com/2016/09/bsx-announces-kickstarte...
Re: Why I’m Digging Deep Into Alzheimer’s
#147We could use all sorts of data, not just from research or pharmaceutical companies. Is there an overview of what data is available or planned for, from clinical to commercial? And what data-integration platforms are planned for? I suspect many countries are trying to invent this on their own, while a world-wide approach could yield better results.
Re: Why I’m Digging Deep Into Alzheimer’s
#148Re: Why I’m Digging Deep Into Alzheimer’s
#149Alzheimer is essentially type 3 diabetes. I'm happy to see Gates behind this.
Re: Why I’m Digging Deep Into Alzheimer’s
#150> We need to use data better. Every time a pharmaceutical company or a research lab does a study, they gather lots of information. We should compile this data in a common form [...] We could use all sorts of data, not just from research or pharmaceutical companies. Is there an overview of what data is available or planned for, from clinical to commercial? And what data-integration platforms are planned for? I suspect…